Kenneth R. Chien
Kenneth R. Chien (born 1951) is an American doctor and medical scientist who has been a research director at
Karolinska Institute, in Stockholm, since 2013. Chien has several papers with over 1,000 citations and a h-index of 132. His area of expertise is cardiovascular science. His research into regenerative
cardiovascular medicine, specifically while director of the Cardiovascular Program of the Harvard Stem Cell Institute, led to his co-founding, in 2010, of ModeRNA Therapeutics. In 2018, the company re-branded as
Moderna, Inc. Chien is a recipient of the
Walter Bradford Cannon Award of the
American Physiology Society and the
Pasarow Award. He is a member of the
Norwegian Academy of Science and Letters, the Austrian Academy of Sciences, and has received an honorary doctorate from the University of Edinburgh.
Provided by Wikipedia